Comvita Investment in Apiter – update

Comvita (NZX:CVT) confirms the purchase of 20% of Apiter S.A., as announced on 20 June 2018, is now complete. Today, Comvita issued 154,686 shares from existing Treasury Stock, in accordance with the terms of the agreement. Please see attached notice in relation to NZX Main Board Listing Rule 7.12.1. Ends For further information: Comvita Chief Commercial Officer, Mark Sadd, 027 707 9698 Comvita Chair, Neil Craig, 021 731 509 About Comvita (www.comvita.co.nz) Comvita is a global natural health products company committed to the development of innovative products, backed by ongoing investment in scientific research. About Apiter Established in 1978 in Uruguay, Apiter is the largest manufacturer of propolis in South America, with processing and manufacturing plants in Uruguay and Argentina. It has decades of experience manufacturing value-add wound care. Extracts are sold as raw materials or manufactured into Apiter's proprietary products; the majority of sales are propolis dressings and pharmaceutical products with a small portion of nutraceuticals and veterinary products. End CA:00320318 For:CVT Type:SECISSUE Time:2018-07-03 16:35:07